Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy S Tracy

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|February 22, 2007
Use of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9Charles W Locuson, Peter M Gannett, Robyn Ayscue, et al.
Journal of Clinical Pharmacology|August 20, 2016
CYP2C9 Genotype-Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative MetabolitesDarcy R Flora, Allan E Rettie, Richard C Brundage, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 21, 2007
CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysisCharles W Locuson, Larry C Wienkers, Jeffrey P Jones, et al.
Biochemistry|June 2, 2004
Effector-mediated alteration of substrate orientation in cytochrome P450 2C9Matthew A Hummel, Peter M Gannett, Jarrett S Aguilar, et al.
Biochemical Pharmacology|August 23, 2005
CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoinTina M Bland, Robert L Haining, Timothy S Tracy, et al.
Biochemistry|October 17, 2008
Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9Carrie M Mosher, Matthew A Hummel, Timothy S Tracy, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Case study 3. Application of basic enzyme kinetics to metabolism studies: real-life examplesYongmei Li, Michelle McCabe, Lalitha Podila, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 8, 2008
Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/-)-suprofen: a comparison of kinetics and probe substrate selectionJ Matthew Hutzler, Larissa M Balogh, Michael Zientek, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 2, 2008
Differential genotype dependent inhibition of CYP2C9 in humansVikas Kumar, Richard C Brundage, William S Oetting, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
Validation of incorporating flurbiprofen into the Pittsburgh cocktailNathalie K Zgheib, Reginald F Frye, Timothy S Tracy, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|February 22, 2007
Use of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9Charles W Locuson, Peter M Gannett, Robyn Ayscue, et al.
Journal of Clinical Pharmacology|August 20, 2016
CYP2C9 Genotype-Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative MetabolitesDarcy R Flora, Allan E Rettie, Richard C Brundage, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 21, 2007
CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysisCharles W Locuson, Larry C Wienkers, Jeffrey P Jones, et al.
Biochemistry|June 2, 2004
Effector-mediated alteration of substrate orientation in cytochrome P450 2C9Matthew A Hummel, Peter M Gannett, Jarrett S Aguilar, et al.
Biochemical Pharmacology|August 23, 2005
CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoinTina M Bland, Robert L Haining, Timothy S Tracy, et al.
Biochemistry|October 17, 2008
Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9Carrie M Mosher, Matthew A Hummel, Timothy S Tracy, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Case study 3. Application of basic enzyme kinetics to metabolism studies: real-life examplesYongmei Li, Michelle McCabe, Lalitha Podila, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 8, 2008
Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/-)-suprofen: a comparison of kinetics and probe substrate selectionJ Matthew Hutzler, Larissa M Balogh, Michael Zientek, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 2, 2008
Differential genotype dependent inhibition of CYP2C9 in humansVikas Kumar, Richard C Brundage, William S Oetting, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
Validation of incorporating flurbiprofen into the Pittsburgh cocktailNathalie K Zgheib, Reginald F Frye, Timothy S Tracy, et al.
Pageof 8